(NASDAQ: AWH) Aspira Women's Health's forecast annual revenue growth rate of 19.01% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.09%.
Aspira Women's Health's revenue in 2024 is $8,991,000.On average, 1 Wall Street analysts forecast AWH's revenue for 2024 to be $133,209,778, with the lowest AWH revenue forecast at $133,209,778, and the highest AWH revenue forecast at $133,209,778.
In 2025, AWH is forecast to generate $174,293,168 in revenue, with the lowest revenue forecast at $174,293,168 and the highest revenue forecast at $174,293,168.